Rivaroxaban treatment for young patients with pulmonary embolism (Review)

MLA

Yang Liu, et al. “Rivaroxaban Treatment for Young Patients with Pulmonary Embolism (Review).” Experimental and Therapeutic Medicine, vol. 20, May 2020, pp. 694–704. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b186e5a20303b7eb7304e20fa3a5cd96&authtype=sso&custid=ns315887.

APA

Yang Liu, Zikai Song, Xiao-Yan Xu, Minglong Tang, Haidi Wu, Ling Qin, Hongyan Cao, & Shuo Yang. (2020). Rivaroxaban treatment for young patients with pulmonary embolism (Review). Experimental and Therapeutic Medicine, 20, 694–704.

Chicago

Yang Liu, Zikai Song, Xiao-Yan Xu, Minglong Tang, Haidi Wu, Ling Qin, Hongyan Cao, and Shuo Yang. 2020. “Rivaroxaban Treatment for Young Patients with Pulmonary Embolism (Review).” Experimental and Therapeutic Medicine 20 (May): 694–704. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b186e5a20303b7eb7304e20fa3a5cd96&authtype=sso&custid=ns315887.